David James: Achieving process integrity in cell therapy production
20 September 2011
David James, Invetech Director, Life Science and Pharmaceutical, speaks at IBC's inaugural Cell Therapy Bioprocessing conference in Virginia, USA during October.
Focussing on bioprocessing challenges and opportunities that are unique to the cell therapy industry, the conference highlights the latest scientific and technical innovations that are helping to build the bridge from development to commercialization.
Following on from previous speaking engagements outlining strategies to achieve cell therapy commercialization and a path for implementation, David shares his insights into how risk-based design, closed consumables and automation address the risks associated with manual laboratory scale processes, and ensures that every cell therapy product is processed in the same way, every time.
For more information about the conference or to register, visit the conference website.
Session: Process Development Integrity & Control
Case Study: Achieving Process Integrity in Production: Understanding Process Robustness and Reproducibility
Tuesday 18 October 2011
Time: 9.15 am – 9.45 am
Cell Therapy Bioprocessing Conference
October 17-18, 2011
Hyatt Regency Reston, Reston, VA
Further Press Information
Alan Morris, Phone: +613 9211 7815, Fax: +613 9211 7703. Media Inquiries.